4 Results for "

TTP 488

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "TTP 488" in MCE Product Catalog:

17
17 Cited Publications
Art. -Nr.: HY-50682
CAS. Nr.: 603148-36-3
Synonyms: TTP488; PF-04494700
Target:  

Amyloid-β

Forschungsgebiete:  

Neurological Disease Cancer

Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...
Art. -Nr.: HY-50682S
Synonyms: TTP488-d9; PF-04494700-d9
Azeliragon-d9 (TTP488-d9) is the deuterium labeled Azeliragon (HY-50682). Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...
Art. -Nr.: HY-50682A
CAS. Nr.: 1284150-65-7
Synonyms: TTP488 dihydrochloride; PF-04494700 dihydrochloride
Target:  

Amyloid-β

Forschungsgebiete:  

Neurological Disease Cancer

Azeliragon dihydrochloride (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon dihydrochloride also can cross the blood-brain barrier (BBB) .
loading...
    loading...
Art. -Nr.: HY-50682R
CAS. Nr.: 603148-36-3
Synonyms: TTP488 (Standard); PF-04494700 (Standard)
Forschungsgebiete:  

Neurological Disease Cancer

Azeliragon (Standard) is the analytical standard of Azeliragon. This product is intended for research and analytical applications. Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...